New Model Predicts Survival for People with Bladder Cancer Receiving Immunotherapy – UroToday
|
New Model Predicts Survival for People with Bladder Cancer Receiving Immunotherapy
UroToday “In just the past few years, the U.S. Food and Drug Administration has approved five new immunotherapies for urothelial cancers,” said lead study author Gregory Pond, PhD, associate professor, McMaster University, Hamilton, Ontario, Canada. “Based on … |
